- Report
- July 2022
- 100 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- September 2024
- 232 Pages
China
From €3803EUR$4,000USD£3,195GBP
- Report
- September 2024
- 99 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- July 2024
- 96 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- February 2023
- 248 Pages
Global
From €3394EUR$3,570USD£2,851GBP
The Cardiovascular Prosthetic market is a subset of the Cardiovascular Devices market, which includes a range of products used to diagnose, treat, and manage cardiovascular diseases. Cardiovascular Prosthetics are medical devices used to replace or support the function of a patient's heart or blood vessels. These devices are typically implanted in the body and can include artificial heart valves, stents, and pacemakers. Cardiovascular Prosthetics are designed to improve the quality of life for patients with cardiovascular diseases, and can help reduce the risk of complications and death.
The Cardiovascular Prosthetic market is highly competitive, with a range of companies offering products for both the diagnosis and treatment of cardiovascular diseases. Companies in the market include Medtronic, Abbott, Boston Scientific, Edwards Lifesciences, and Sorin Group. Show Less Read more